Gabather AB (publ) (GABA.ST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Michael-Robin Witt | CEO & Director | 1.13M | -- | -- |
| Mr. Kristofer Svensson | Chief Financial Officer | 319k | -- | 1982 |
| Dr. Christine Ryan | Chief Operating Officer | -- | -- | -- |
| Mr. Stefan Rehnmark | C S O | -- | -- | 1956 |
Gabather AB (publ)
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Gabather AB (publ), a pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company develops GT-002 for the treatment of schizophrenia, major depressive disorder, orphan drug, and alzheimer´s disease. It has a collaborative agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatric Centre in Glostrup to conduct a so-called clinical phase II study with GT-002 in patients diagnosed with schizophrenia. Gabather AB (publ) was incorporated in 2014 and is based in Södertälje Sweden.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available